Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hepatitis × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 53 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Lymphoma 43 Burkitt Lymphoma 34 Lymphoma, Follicular 32 Myelodysplastic Syndromes 31 Lymphoma, Large B-Cell, Diffuse 31 Lymphoma, Non-Hodgkin 30 Multiple Myeloma 29 Leukemia, Myeloid, Acute 28 Leukemia, Myeloid, Chronic-Phase 26 Leukemia, Myeloid, Accelerated Phase 24 Lymphoma, Large-Cell, Immunoblastic 23 Leukemia, Lymphocytic, Chronic, B-Cell 23 Blast Crisis 20 Graft vs Host Disease 19 Neoplasms, Plasma Cell 18 Myeloproliferative Disorders 18 Hodgkin Disease 18 Dendritic Cell Sarcoma, Interdigitating 18 Recurrence 17 Lymphoma, Mantle-Cell 17 Lymphoma, B-Cell, Marginal Zone 17 Leukemia, Myelomonocytic, Chronic 15 Leukemia, Biphenotypic, Acute 15 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 13 Congenital Abnormalities 13 Primary Myelofibrosis 12 Anemia, Refractory, with Excess of Blasts 12 Myelodysplastic-Myeloproliferative Diseases 11

Interventions

bavituximab 1 Ursodeoxycholic Acid 1 Steroids 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡